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Collateral branches can be covered without compromising the ﬂow and risk of renal
infarction. It is a safe procedure with a very low complications rate. Larger study is
ongoing.
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RENAL ANGIOPLASTY AND STENTING. LIMITATIONS. ROLE OF
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Background: Despite good immediate and long-term results, post procedural dete-
rioration of the renal function (RF) may occur after Renal Artery Angioplasty and
Stenting (RAAS) in 20-40 % of the patients, which limits the immediate beneﬁts of
the technique. Atheroembolism seems to play an important role. We evaluate feasi-
bility and safety of RAAS utilizing a distal protection device (DPD) to reduce the risk
of atheroembolism and avoid deteriorations of the RF.
Methods: 171 RAAS performed under DPD in 151 hypertensive patients (M:102).
Mean age: 65.2  10.8 yrs with atherosclerotic renal artery stenosis (20 bilateral). 11
pts had solitary kidneys, 62 renal insufﬁciencies. We used occlusion balloon (n ¼ 46)
or ﬁlters (n ¼ 125). We recently experimented and treated 12 patients with a new ﬁlter
the Fibernet (Lumen Biomedical Plymouth MN) which can capture particles of 40m
without compromising the ﬂow. Generated debris removed and analyzed. Blood
pressure and serum creatinine levels followed. Techniques of RAAS under protection,
limitations will be discussed.
Results: Immediate technical success: 100 %. Visible debris aspirated with Percu-
surge from all patients. Mean particle number: 98.1  60.00. Mean diameter: 201.2 
76m (38-6206). With current ﬁlters debris were removed in 80 % of the cases. With the
Fibernet visible debris were removed in all cases. Mean debris surface area: 121mm2.
Mean number of particles 28-60m : 2136  776, >60m. We observed one acute RF
deterioration. Mean follow-up: 32.2  17 months. Mean creatinine level remains
constant during follow-up. At 6 months (131 patients) 95 patients stabilized, 35 with
baseline renal insufﬁciency improved and we had only one RF deterioration (1 %) in a
patient with moderate renal insufﬁciency. At 2 years (105 patients) 73 stabilized, 28
improved and we only had 4 RF deterioration (4 %).
Conclusions: This study demonstrates the feasibility and safety of DPD during renal
interventions to protect against atheroembolism and seems to avoid RF deterioration
after the procedure and in the long-term. Indications will be discussed. Improvements
in DPD for renal stenting are mandatory. Randomized studies are awaited.Peripheral Vascular: Miscellaneous and Other
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Treatment of Acute Pulmonary Embolism with Rheolytic Thrombectomy
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Mindaugas Mataciunas1, Vytautas Abraitis2, Diana Zakarkaite3, Sigute Aidietiene1,
Audrius Aidietis4
1Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithiania, 2Vilnius
University, Vilnius, Lithiania, 3Vilnius University, Vilnius, Vilnius, 4Vilnius University
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Background: Percutaneous rheolytic thrombectomy with AngioJet catheter can be
applied in patients with cardiogenic shock or severe right ventricular dysfunction due
to massive pulmonary embolism. The aim: to report a single center expierence in
applying rheolytic thrombectomy treatment of massive pulmonary embolism.
Methods: Percutaneous rheolytic thrombectomy was performed in 20 patients with
acute massive pulmonary embolism between September 2009 and November 2013.
All patients had contraindications against systemic thrombolysis. Twenty patients (a
mean age of 58.4  15.3 years, female n¼7 (one of them 22 week of pregnancy)
underwent percutaneous rheolytic thrombectomy with AngioJet Xpeedior Catheter.
Cardiogenic shock was present in 4 patients (shock index 1), severe right ventricular
dysfunction was present in 16 patients, Troponin mean value 0.669  0.176 mkg/l and
Brain Natriuretic Peptide mean value 330.7  87 ng/l. Selective thrombolysis mean
dose 30 mg of tissue plasminogen activators was given to 11 patients.
Results: The rheolytic thrombectomy procedure was technically successful in 18
cases. The perfusion systolic and mean pulmonary pressures improved from mean
57.915.8 mmHg to 48.214.76 mmHg (systolic) and from mean 34.37.56 mmHg
to 28.96.99 mmHg (mean) (p< 0.001). The shock index decreased from 0.91 toB150 JACC Vol 64/11/Suppl B j September 13–10.735 (p¼0.001). All patients survived in hospital stay, hemoptysis was noted in 2
patients (one required blood transfusion) and transient renal failure requiring dialysis
in 4 patients. Right ventricular diastolic diameter decreased from mean 3.690.57 cm
at baseline, to 3.10.33 cm 24 hours after rheolytic thrombectomy, to 2.780.31 cm
at one month , 2.730.32 cm at six months and 2.680.37 cm at one year of follow
up. From 15 patients at one year follow-up period, four patients demonstrated evi-
dence of mild cor pulmonale. The pregnant woman successfully delivered a full-term
newborn.
Conclusions: Percutaneous rheolytic thrombectomy using the AngioJet catheter is an
effective treatment method for massive pulmonary embolism when systemic throm-
bolysis is contraindicated. More data with the comparison of this method and systemic
lytic therapy in the treatment of acute PE are required.
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Background: In patients with massive pulmonary embolism the treatment choices
are systemic ﬁbrinolysis and surgical embolectomy as both methods are proved to
reverse right ventricular failure and cardiogenic shock. In one third of patients
systemic ﬁbrinolysis is contraindicated and surgical treatment is high risk and not
widely available. A feasible alternative of those treatments are percutaneous catheter
technics.
Methods: All 20 patients were with PE and hemodynamic instability deﬁned as a
systolic arterial pressure  90 mm Hg or drop of systolic pressure of  40 mm Hg for
over 15 min or need for catecholamine administration, and echocardiographic evi-
dence for RV dysfunction. We used right or left common femoral vein for access site
with insertion of 8 Fr sheath. Hemodynamic assessment was obtained before and at
the end of the procedure. After insertion of 5 Fr Pigtail catheter consecutively in the
right and left main branch a local administration of alteplase 25 mg was performed
through the Pigtail catheter. With 0.035 inch guidwire through the pigtail a rotational
thrombus fragmentation was performed. After the catheter directed thrombolysis and
rotational thrombus fragmentation a precise selective angiography was made with a 8
Fr guiding catheter JR in all segmental branches of the pulmonary artery with diameter
above 6 mm. A meticulous thrombus aspiration was then performed in all segmental
branches that were involved through the same catheter.
Results: From the analyzed 20 patients 63% were male with a mean age of 54 years.
The in-hospital survival was 92.7% as only one patients died due to lung infection. In
24 hours after the procedure there was an increase in both O2 saturation (91,5% vs
96,27%, p< 0.001) and pO2(66,4 vs. 96,5 mm Hg, p< 0.001). The right ventricular
basal diameter decreased (48 mm vs. 38 mm, p< 0.001) and TAPCE was increased
(13 mm vs. 20 mm p¼0.001). The systolic (70 mmHg vs. 51 mmHg p¼0.03) and
mean (45 mmHg vs. 34 mmHg, p¼0.001) pulmonary artery pressure also decreased.
At 6 months follow- up all patients were alive with NYHA  II class heart failure.
Conclusions: The described technique is effective and save method for treatment of
high risk patients with PE.
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Catheter directed thrombolysis and mechanical thrombectomy pulmonary
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Background: Percutaneous thrombectomy and catheter directed thrombolysis (CDT)
represent well established techniques for treatment of submassive pulmonary embo-
lism (SPE). The purpose of CDT is to dissolve thrombus and to restore the lumen
without causing distal embolization as fast as possible.
Methods: We have enrolled in 2011-2013 our patients with SPE in a prospective
register and we have analysed our patients clinical, interventional and echocardio-
graphic data. We have examined the efﬁcacy and safety of CDT in the treatment of
SPE. The access site for SPE was the femoral. Caval ﬁlters were implanted from
jugular or from femoral veins. After the sheath advancement, occlusions were passed
with a 0.035 guidewire and CDT was started with Alteplase over a pig tail catheter for
12-24 hours. After 24 hours, control pulmonary angiography was performed and the
CDT was maintained when the thrombus burden was ﬂow limiting or the pulmonary
pressure has not decreased with 50%. When the CDT was not successful, manual
thrombectomy and thrombus fragmentation was performed with a 7F guiding and pig
tail catheter. Postoperatively, patients were treated with systemic anticoagulation,
compression hose, and interval follow-up.
Results: 26 patients were treated with a mean age of 52.514.9 years. CDT was
successful after the ﬁrst post-operative day in 19 patients (73%) but in 7 patients
(27%) thrombus aspiration and thrombectomy was performed after failed thrombol-
ysis. In two patients (7.2%) caval ﬁlters were implanted. Good angiographic and
clinical outcome was achieved in 25 patients (96.15%). The invasive pulmonary
pressure has dropped from 60.78  18.67 to 19.7  12.36 Hgmm after the procedure
(p< 0.05). Echocardiography parameters were normalized in 25 patients (96.15).7, 2014 j TCT Abstracts/Peripheral Vascular: Miscellaneous and Other
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mesenteric ischemia. Access site complications occurred in 2 patients (7.7%).
Conclusions: Submassive pulmonary embolism ha excellent results with catheter
directed thrombolysis, however additional mechanical thrombectomy and angioplasty
is necessary in several patients to achive good clinical outcome.
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Carlos Fernandez-Pereira1, Alfredo M. Rodriguez-Granillo2, Juan Mieres2,
Roberto Cristodulo3, Paola Renes3, Lorena Arizmendi1, Jhon R. Aldana1,
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Background: Massive Pulmonary Embolism (MPE) is an important cause of death
around the world. In unstable patients (pts), Percutaneous Rheolytic Thrombectomy
(PRT) is a treatment option, especially in those unable for surgical thrombectomy or
with absolute contraindications for ﬁbrinolysis. We are reporting retrospective in-
hospital and late outcome of unstable pts treated with PRT.
Methods: Between December 2009 and April 2013 in two university Hospitals in
Buenos Aires, Argentina, we included 14 consecutive pts with MPE according to the
American College of Chest Physicians guidelines and conﬁrmed by multislice
computed tomography and doppler ultrasound (US), moderate to severe right ventric-
ular failure and contraindication or ﬁbrinolysis therapy failure. All pts (or direct rela-
tives) signed an Informed Consent Form previously to treatment with Angiojet
thrombectomy system (Bayer HealthCare, Germany). Pre-procedure Shock Index (heart
rate/systolic arterial pressure) and pulmonary systolic pressure pre and post procedure
were obtained. Miller score was estimated after pulmonary angiogram was performed.
Primary endpoint was in-hospital death and any bleeding. During follow-up an US was
done at 3 months after discharge to assess right ventricular function and pulmonary
pressures. Long term follow-up was done to assess heart failure or functional class.
Results:Mean age was 64.5 +/- 14.3 years, 64.3% were male, with BMI>30¼71.4%,
previous malignant neoplasia in 14.2%, chronic obstructive pulmonary disease¼9.1%
and immobility¼71.4%. Pre-procedure shock index was 1.43+/-0.23. After procedure
Miller Score and systolic pulmonary pressures improved signiﬁcantly (p< 0.001 for
both). After PRT and before 30 days one patient died and no bleeding was reported.
During 25.7 +/-21 months of follow-up global mortality was 28.5% (none cardiac
related) and 2 pts showed evidence of mild cor pulmonale.
Conclusions: Percutaneous Pulmonary Rheolytic thrombectomy was safe and effec-
tive for the treatment of these high risk patients. Long-term outcome was related to the
underlying pathology.
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Background: There are limited therapuetic options for high risk patients with massive
or sub-massive pulmonary embolism. The use of ultrasound-assisted catheter directed
thrombolysis(UA-CDT) has shown to be particularly promising in various small
studies. We aimed to conduct a meta-analysis of the available published studies.
Methods: An extensive time unlimited literature search using MEDLINE, EMBASE
& Cochrane databases using MeSH key words ‘pulmonary embolism’, ‘ultrasound’
and ‘catheter-directed’ identiﬁed 7 studies including a total of 240 patients. Of these
197 patients underwent use of Ekosonic catheter directed thrombolytic therapy
(UCDT) for massive or sub-massive PE. Hemodynamic measures including mean &
systolic pulmonary artery pressure, RV-LV ratio, heart rate and cardiac index were
assessed before and after therapy. Meta-analysis was performed using Cochrane
Collaboration Review Manager(version 5.1). Effect size was estimated using random
effects model and mean difference with 95% conﬁdence intervals were calculated.
Results: One hundred and thirty patients were treated with UCDT. Massive &
bilateral PE was reported in 74(30.8%) & 152(63.3%) patients respectively. UCDT
resulted in a signiﬁcant reduction in PA systolic (mean -15.22mmHg;95% CI -21.01–
9.43) & mean PA pressures(mean -9.35mmHg;95% CI -13.03- -5.68), in addition to a
24% increase in cardiac index. The RV size, assessed by the ratio of RV to LV di-
mensions, was reduced with UCDT(mean -0.35;95% CI -0.42- -0.28), & the heart rate
decreased by 16.9 beats/min (95% CI -26.46 - -7.34). The Miller pulmonary artery
occlusion score (in 87 patients)showed a signiﬁcant reduction of 10.12 points (95% CI
-12.21 - -8.02). Thirty & 90-day all-cause mortality was 3.1% (6/197)& 4.6%(7/152)
respectively with UCDT. Recurrent events & major bleeding was reported in 2/
115(1.7%) & 7 patients(3.5%)respectively.
Conclusions: In this largest meta-analysis to-date evaluating the impact of UCDT on
massive & sub-massive PE, UCDT is associated with signiﬁcant improvements in
hemodynamic measures of RV & LV function. The procedure appears to be safe & is
associated with low 30 & 90-day mortality compared to RIETE(8.65%) and ICOPER
registries(17.4%).JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/PeTCT-514
Percutaneous Transluminal Angioplasty of the Subclavian Arteries. Long-Term
Follow up
Isabelle Henry1, Michel C. Henry2, Amira Benjelloun3
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nancy, France, 3Clinique Coeur et Vaisseaux, RABAT, Morocco
Background: To review feasibility, safety and long-term results of subclavian artery
angioplasty.
Methods: 407 patients (males: 245, mean age: 66.1  12 y) underwent percutaneous
treatment for subclavian artery (SA) occlusive disease (stenosis: 295, occlusion: 112).
Left: 312, Right: 95, Innominate Artery: 28. Etiology: atheromatous: 397, others: 10
(Takayasu: 6) Mean % stenosis 83.4 +/- 7.8. Mean lesion length: 23.9 +/- 8.7 mm
Indications for treatment were upper limb ischemia (ULI) (n¼177) Vertebrobasilar
insufﬁciency (VBI) (n¼157), associated VBI and ULI (n¼123), coronary steal syn-
drome (n¼20) asymptomatic patients with severe coronary disease (n¼73) 39 patients
had associated Vertebral Artery stenosis, 81 carotid stenoses. 337 prevertebral lesion,
45 post vertebral, both 25. Access: femoral (n¼287), brachial (n¼81), both (n¼39).
“Pull through technique”: 8 cases. An isolated balloon angioplasty was performed in 59
cases and 348 stents were implanted (balloon expandable: 276, self expandable: 72).
Results: Technical success was obtained in 387 lesions (95 %) 100% for stenoses.
Only 92 occlusions were recanalized (82 %). Four periprocedural events occurred (1.2
%), 1 major (fatal stroke), 1 T.I.A., 2 arterial thromboses. During the follow-up (mean
follow-up: 75.7 months  38.5), we had 40 restenoses (10 %). 13 occurred following
angioplasty alone (18.8 %) and 27 following angioplasty and stent implantation (7.8 %)
(P< 0.01). 10 were treated by new angioplasty alone, 30 by repeat stent implantation.
Primary (PI) and secondary (PII) patencies on an intention to treat basis at 10-year follow-
up were 80.2 % and 86.5 % respectively. In patients without initial stent placement,
the rates were 67.5 % and 75.5 % while in those with stents, the rates rose to 91.5 % and
98.2 % (P< 0.01). PI for all recanalized lesions were 85.8 %, 79.1 % without stent, 91.8
% with stent (P < 0.04) and PII 92.8 %, 88.5 %, 98.1% respectively (P < 0.02).
Conclusions: P.T.A. is currently the treatment of choice for subclavian artery lesions.
It is a safe and effective procedure associated with low risks and good long-term
results. Stents seem to limit the restenosis rate and improve long-term results.
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PUDENDAL ARTERY ANGIOPLASTY FOR THE TREATMENT OF
COMPLEX ERECTILE DYSFUNCTION IN MALES
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Background: Erectile Dysfunction (E D) is an important and growing health problem.
It is estimated that more than 200 million men (between the age of 40 – 70 years)
suffer from ED . The real prevalence could be much higher as it is under reported and
under treated. Out of the many etiologies, 80 % of cases are because of vasculogenic
origin. Venous leak and Arterial Inﬂow problems (usually pudendal artery stenosis)
are the most common etiologies. In patients who fail PDE – 5 inhibitors therapy
(Complex ED), vasculogenic causes should be strongly suspected.
Methods: The workup is done by excluding the endocrinal, urological and psychological
causes and then subjecting these patients to a penile Doppler study (after intra cavernosal
injection of papaverine). In patients where the peak systolic penile velocity is less than
25 cm /sec, pudendal artery stenosis is strongly suspected. These patients then undergo a
selective angiography for identiﬁcation of pudendal artery stenosis. If the stenosis is
found they are subjected to super selective pudendal artery cannulation and angioplasty
or stenting using drug eluting balloon (DEB) or zatrolimus eluting stents (DES). Patients
are followed up at 3, 9, 12 months and then after every year by Duplex scans.
Results: 36 consecutive worked up patients of complex ED with pudendal artery ste-
nosis underwent pudendal artery angioplasty (with DEB or DES). The procedure was
successful in all patients There were no death, perineal or penile gangrene. The mean
penile velocity increased from base line of 16 cm / sec to 44 ,50,58 cm /sec at 3, 6, 12
months respectively. Improvement > 4 points in International Index of Erectile Func-
tions (IIEF -6 ) score at 3 , 6 and 12 months were 68 % , 75 % and 78 % respectively.
Conclusions: Angioplasty of focal stenosis of internal pudendal artery by DEB or
DES appears to be a very promising therapy for male erectile dysfunction. It is safe,
feasible and leads to sustained improvement of male erectile dysfunction in about 75
% of carefully selected cases. However still many cases are ineligible for this pro-
cedure . Larger studies are required to be able to accept it as a standard therapy to treat
male Erectile Dysfunction.
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THEMULTILAYER FLOWMODULATOR STENT FOR THE TREATMENT
OF PERIPHERAL AND VISCERAL ANEURYSMS
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Background: Arterial aneurysms (An) are traditionally treated surgically, but more
and more by interventional procedures with a high technical success rate, but some
problems are not solved like protection of aneurysm rupture, endoleaks, stentripheral Vascular: Miscellaneous and Other B151
